Functional Repair of Brain Death-Induced Injury

  • Henri G. D. Leuvenink
  • Marc A. Seelen
  • Rutger J. Ploeg


The abnormal physiological state of brain death has large implications for the quality of organs donated for transplantation. During the last decade, it was shown that brain death leads to severe imbalance in homeostasis characterized by an inflammatory state of the graft-to-be. Prevention or even repair of brain death-induced injury will lead to organs of better quality, and therefore improved transplant results.


Brain Death Deceased Donor Bronchiolitis Obliterans Syndrome Potential Donor Organ Remote Precondition 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med. 1995;333(6):333–6.PubMedGoogle Scholar
  2. 2.
    Futagawa Y, Waki K, Gjertson DW. Living-unrelated donors yield higher graft survival rates than parental donors. Transplantation. 2005;79:1169–74.PubMedGoogle Scholar
  3. 3.
    Pirsch JD, Ploeg RJ, Gange S. Determinants of graft survival after renal transplantation. Transplantation. 1996;61:1581–6.PubMedGoogle Scholar
  4. 4.
    Port FK, Bragg-Gresham JL, Metzger RA. Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation. 2002;74:1281–6.PubMedGoogle Scholar
  5. 5.
    Ojo AO, Wolfe RA, Held PJ. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation. 1997;63:968–74.PubMedGoogle Scholar
  6. 6.
    Wolfe RA, Ashby VB, Milford EL. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725–30.PubMedGoogle Scholar
  7. 7.
    Merion RM, Ashby VB, Wolfe RA. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA. 2005;294:2726–33.PubMedGoogle Scholar
  8. 8.
    Ojo AO, Hanson JA, Meier-Kriesche H. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol. 2001;12:589–97.PubMedGoogle Scholar
  9. 9.
    Merion RM, Ashby VB, Wolfe RA, et al. Deceased-donor characteristics and the survival benefit of ­kidney transplantation. JAMA. 2005;294(21): 2726–33.PubMedGoogle Scholar
  10. 10.
    Cushing H. Some experimental and clinical observations concerning states of increased intracranial tension. Am J Med Sci. 1902;124:375–400.Google Scholar
  11. 11.
    Novitzky D. Selection and management of cardiac allograft donors. Curr Opin Cardiol. 1996;11: 174–82.PubMedGoogle Scholar
  12. 12.
    Novitzky D, Wicomb WN, Cooper DK. Prevention of myocardial injury during brain death by total cardiac sympathectomy in the chacma baboon. Ann Thorac Surg. 1986;41:520–4.PubMedGoogle Scholar
  13. 13.
    Shivalkar B, van Loon J, Wieland W. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation. 1993;87:230–9.PubMedGoogle Scholar
  14. 14.
    Barklin A, Larsson A, Vestergaard C, et al. Does brain death induce a pro-inflammatory response at the organ level in a porcine model? Acta Anaesthesiol Scand. 2008;52(5):621–7.PubMedGoogle Scholar
  15. 15.
    Chen EP, Bittner HB, Kendall SW, Van Trigt P. Hormonal and hemodynamic changes in a validated animal model of brain death. Crit Care Med. 1996;24(8):1352–9.PubMedGoogle Scholar
  16. 16.
    Herijgers P, Leunens V, Tjandra-Maga TB. Changes in organ perfusion after brain death in the rat and its relation to circulating catecholamines. Transplantation. 1996;62:330–5.PubMedGoogle Scholar
  17. 17.
    Powner DJ, Hendrich A, Nyhuis A. Changes in serum catecholamine levels in patients who are brain dead. J Heart Lung Transplant. 1992;11:1046–53.PubMedGoogle Scholar
  18. 18.
    Sebening C, Hagl C, Szabo G. Cardiocirculatory effects of acutely increased intracranial pressure and subsequent brain death. Eur J Cardiothorac Surg. 1995;9:360–72.PubMedGoogle Scholar
  19. 19.
    Mertes PM, Carteaux JP, Jaboin Y. Estimation of myocardial interstitial norepinephrine release after brain death using cardiac microdialysis. Transplantation. 1994;57:371–7.PubMedGoogle Scholar
  20. 20.
    Biswas SS, Chen EP, Bittner HB. Brain death further promotes ischemic reperfusion injury of the rabbit myocardium. Ann Thorac Surg. 1996;62:1808–15.PubMedGoogle Scholar
  21. 21.
    Nagareda T, Kinoshita Y, Tanaka A, et al. Clinicopathology of kidneys from brain-dead patients treated with vasopressin and epinephrine. Kidney Int. 1993;43(6):1363–70.PubMedGoogle Scholar
  22. 22.
    Salim A, Martin M, Brown C, Rhee P, Demetriades D, Belzberg H. The effect of a protocol of aggressive donor management: implications for the national organ donor shortage. J Trauma. 2006;61(2):429–33; discussion 433–5.Google Scholar
  23. 23.
    Dictus C, Vienenkoetter B, Esmaeilzadeh M, Unterberg A, Ahmadi R. Critical care management of potential organ donors: our current standard. Clin Transplant. 2009;23 Suppl 21:2–9.PubMedGoogle Scholar
  24. 24.
    Bugge JF. Brain death and its implications for management of the potential organ donor. Acta Anaesthesiol Scand. 2009;53(10):1239–50.PubMedGoogle Scholar
  25. 25.
    Arita K, Uozumi T, Oki S. The function of the hypothalamo-pituitary axis in brain dead patients. Acta Neurochir (Wien). 1993;123:64–75.Google Scholar
  26. 26.
    Petty GW, Mohr JP, Pedley TA. The role of transcranial doppler in confirming brain death: sensitivity, specificity, and suggestions for performance and interpretation. Neurology. 1990;40:300–3.PubMedGoogle Scholar
  27. 27.
    Sugimoto T, Sakano T, Kinoshita Y. Morphological and functional alterations of the hypothalamic-pituitary system in brain death with long-term bodily living. Acta Neurochir (Wien). 1992;115:31–6.Google Scholar
  28. 28.
    Gramm HJ, Meinhold H, Bickel U. Acute endocrine failure after brain death? Transplantation. 1992;54: 851–7.PubMedGoogle Scholar
  29. 29.
    Howlett TA, Keogh AM, Perry L. Anterior and posterior pituitary function in brain-stem-dead donors. A possible role for hormonal replacement therapy. Transplantation. 1989;47:828–34.PubMedGoogle Scholar
  30. 30.
    Schuurs TA, Gerbens F, van der Hoeven JA, et al. Distinct transcriptional changes in donor kidneys upon brain death induction in rats: insights in the processes of brain death. Am J Transplant. 2004;4(12): 1972–81.PubMedGoogle Scholar
  31. 31.
    Novitzky D, Cooper DK, Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation. 1987;43(6):852–4.PubMedGoogle Scholar
  32. 32.
    Amado JA, Lopez-Espadas F, Vazquez-Barquero A. Blood levels of cytokines in brain-dead patients: relationship with circulating hormones and acute-phase reactants. Metabolism. 1995;44:812–6.PubMedGoogle Scholar
  33. 33.
    Gifford RR, Weaver AS, Burg JE. Thyroid hormone levels in heart and kidney cadaver donors. J Heart Transplant. 1986;5:249–53.PubMedGoogle Scholar
  34. 34.
    Powner DJ, Hendrich A, Lagler RG. Hormonal changes in brain dead patients. Crit Care Med. 1990;18:702–8.PubMedGoogle Scholar
  35. 35.
    Masson F, Thicoipe M, Latapie MJ. Thyroid function in brain-dead donors. Transpl Int. 1990;3:226–33.PubMedGoogle Scholar
  36. 36.
    Van den Berghe G, Wilmer A, Hermans G. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–61.PubMedGoogle Scholar
  37. 37.
    Van den Berghe G, Wouters P, Weekers F. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–67.PubMedGoogle Scholar
  38. 38.
    Hansen TK, Thiel S, Wouters PJ. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab. 2003;88:1082–8.PubMedGoogle Scholar
  39. 39.
    Langouche L, Vanhorebeek I, Vlasselaers D. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest. 2005;115:2277–86.PubMedGoogle Scholar
  40. 40.
    Matzinger P. The danger model: a renewed sense of self. Science. 2002;296(5566):301–5.PubMedGoogle Scholar
  41. 41.
    Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 1994;12:991–1045.PubMedGoogle Scholar
  42. 42.
    van der Hoeven JA, Ploeg RJ, Postema F. Induction of organ dysfunction and up-regulation of inflammatory markers in the liver and kidneys of hypotensive brain dead rats: a model to study marginal organ donors. Transplantation. 1999;68:1884–90.PubMedGoogle Scholar
  43. 43.
    van der Hoeven JA, Lindell S, Van Schilfgaarde R. Donor brain death reduces survival after transplantation in rat livers preserved for 20 hr. Transplantation. 2001;72:1632–6.PubMedGoogle Scholar
  44. 44.
    Takada M, Nadeau KC, Hancock WW, et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation. 1998;65(12):1533–42.PubMedGoogle Scholar
  45. 45.
    Kusaka M, Pratschke J, Wilhelm MJ, et al. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation. 2000;69(3):405–10.PubMedGoogle Scholar
  46. 46.
    Koo DD, Welsh KI, McLaren AJ. Cadaver versus living donor kidneys: impact of donor factors on antigen induction before transplantation. Kidney Int. 1999;56:1551–9.PubMedGoogle Scholar
  47. 47.
    Kotsch K, Kunert K, Merk V, et al. Novel markers in zero-hour kidney biopsies indicate graft quality and clinical outcome. Transplantation. 2010;90(9): 958–65.PubMedGoogle Scholar
  48. 48.
    Lopau K, Mark J, Schramm L, Heidbreder E, Wanner C. Hormonal changes in brain death and immune activation in the donor. Transpl Int. 2000;13 Suppl 1:S282–5.PubMedGoogle Scholar
  49. 49.
    Damman J, Nijboer WN, Schuurs TA, et al. Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation. Nephrol Dial Transplant. 2011;26:2345–54.PubMedGoogle Scholar
  50. 50.
    Francuski M, Reutzel-Selke A, Weiss S, et al. Donor brain death significantly interferes with tolerance induction protocols. Transpl Int. 2009;22(4): 482–93.PubMedGoogle Scholar
  51. 51.
    Koudstaal LG, ‘t Hart NA, Ottens PJ, et al. Brain death induces inflammation in the donor intestine. Transplantation. 2008;86(1):148–54.PubMedGoogle Scholar
  52. 52.
    Koudstaal LG, ‘t Hart NA, van den Berg A, et al. Brain death causes structural and inflammatory changes in donor intestine. Transplant Proc. 2005; 37(1):448–9.PubMedGoogle Scholar
  53. 53.
    Koo DD, Welsh KI, Roake JA. Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion. Am J Pathol. 1998;153:557–66.PubMedGoogle Scholar
  54. 54.
    Pratschke J, Wilhelm MJ, Kusaka M, et al. Accelerated rejection of renal allografts from brain-dead donors. Ann Surg. 2000;232(2):263–71.PubMedGoogle Scholar
  55. 55.
    Zweers N, Petersen AH, van der Hoeven JA. Donor brain death aggravates chronic rejection after lung transplantation in rats. Transplantation. 2004;78: 1251–8.PubMedGoogle Scholar
  56. 56.
    Wilhelm MJ, Pratschke J, Laskowski IA. Altered alloimmune response toward grafts from brain-dead donors in chronic rat cardiac allograft rejection. Transplant Proc. 2001;33:366–7.PubMedGoogle Scholar
  57. 57.
    Apostolakis E, Parissis H, Dougenis D. Brain death and donor heart dysfunction: implications in cardiac transplantation. J Card Surg. 2010;25(1):98–106.PubMedGoogle Scholar
  58. 58.
    van den Eijnden MM, Leuvenink HG, Ottens PJ, et al. Effect of brain death and non-heart-beating kidney donation on renal function and injury: an assessment in the isolated perfused rat kidney. Exp Clin Transplant. 2003;1(2):85–95.PubMedGoogle Scholar
  59. 59.
    Wicomb WN, Cooper DK, Novitzky D. Impairment of renal slice function following brain death, with reversibility of injury by hormonal therapy. Transplantation. 1986;41:29–33.PubMedGoogle Scholar
  60. 60.
    Morariu AM, Schuurs TA, Leuvenink HG, van Oeveren W, Rakhorst G, Ploeg RJ. Early events in kidney donation: progression of endothelial activation, oxidative stress and tubular injury after brain death. Am J Transplant. 2008;8(5):933–41.PubMedGoogle Scholar
  61. 61.
    Ichimura T, Bonventre JV, Bailly V, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 1998;273(7):4135–42.PubMedGoogle Scholar
  62. 62.
    Nijboer WN, Schuurs TA, Damman J, et al. Kidney injury molecule-1 is an early noninvasive indicator for donor brain death-induced injury prior to kidney transplantation. Am J Transplant. 2009;9(8):1752–9.PubMedGoogle Scholar
  63. 63.
    Hoeger S, Petrov K, Reisenbuechler A, et al. The additional detrimental effects of cold preservation on transplantation-associated injury in kidneys from living and brain-dead donor rats. Transplantation. 2009;87(1):52–8.PubMedGoogle Scholar
  64. 64.
    Nijboer WN, Schuurs TA, van der Hoeven JA, et al. Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation. 2004;78(7):978–86.PubMedGoogle Scholar
  65. 65.
    Bos EM, Schuurs TA, Kraan M, et al. Renal expression of heat shock proteins after brain death induction in rats. Transplant Proc. 2005;37(1):359–60.PubMedGoogle Scholar
  66. 66.
    Kunzendorf U, Hohenstein B, Oberbarnscheid M. Duration of donor brain death and its influence on kidney graft function. Am J Transplant. 2002;2:292–4.PubMedGoogle Scholar
  67. 67.
    Nijboer WN, Moers C, Leuvenink HG, Ploeg RJ. How important is the duration of the brain death period for the outcome in kidney transplantation? Transpl Int. 2011;24(1):14–20.PubMedGoogle Scholar
  68. 68.
    Wauters S, Verleden GM, Belmans A, et al. Donor cause of brain death and related time intervals: does it affect outcome after lung transplantation? Eur J Cardiothorac Surg. 2011;39(4):e68–76.PubMedGoogle Scholar
  69. 69.
    Schuurs TA, Morariu AM, Ottens PJ, et al. Time-dependent changes in donor brain death related processes. Am J Transplant. 2006;6(12):2903–11.PubMedGoogle Scholar
  70. 70.
    Ozaki KS, Marques GM, Nogueira E, et al. Improved renal function after kidney transplantation is associated with heme oxygenase-1 polymorphism. Clin Transplant. 2008;22(5):609–16.PubMedGoogle Scholar
  71. 71.
    Baan C, Peeters A, Lemos F. Fundamental role for HO-1 in the self-protection of renal allografts. Am J Transplant. 2004;4:811–8.PubMedGoogle Scholar
  72. 72.
    Turpeinen H, Kyllonen LE, Parkkinen J, Laine J, Salmela KT, Partanen J. Heme oxygenase 1 gene polymorphisms and outcome of renal transplantation. Int J Immunogenet. 2007;34(4):253–7.PubMedGoogle Scholar
  73. 73.
    Courtney AE, McNamee PT, Middleton D, Heggarty S, Patterson CC, Maxwell AP. Association of functional heme oxygenase-1 gene promoter polymorphism with renal transplantation outcomes. Am J Transplant. 2007;7(4):908–13.PubMedGoogle Scholar
  74. 74.
    Geuken E, Buis CI, Visser DS, et al. Expression of heme oxygenase-1 in human livers before transplantation correlates with graft injury and function after transplantation. Am J Transplant. 2005;5(8): 1875–85.PubMedGoogle Scholar
  75. 75.
    Ollinger R, Pratschke J. Role of heme oxygenase-1 in transplantation. Transpl Int. 2010;23(11):1071–81.PubMedGoogle Scholar
  76. 76.
    McLean KM, Duffy JY, Pandalai PK, et al. Glucocorticoids alter the balance between pro- and anti-inflammatory mediators in the myocardium in a porcine model of brain death. J Heart Lung Transplant. 2007;26(1):78–84.PubMedGoogle Scholar
  77. 77.
    McLean KM, Pandalai PK, Pearl JM, et al. Beta-adrenergic receptor antagonism preserves myocardial function after brain death in a porcine model. J Heart Lung Transplant. 2007;26(5):522–8.PubMedGoogle Scholar
  78. 78.
    Lyons JM, Pearl JM, McLean KM, et al. Glucocorticoid administration reduces cardiac dysfunction after brain death in pigs. J Heart Lung Transplant. 2005;24(12):2249–54.PubMedGoogle Scholar
  79. 79.
    Pratschke J, Kofla G, Wilhelm MJ. Improvements in early behavior of rat kidney allografts after treatment of the brain-dead donor. Ann Surg. 2001;234:732–40.PubMedGoogle Scholar
  80. 80.
    Gasser M, Waaga AM, Kist-van Holthe JE. Normalization of brain death-induced injury to rat renal allografts by recombinant soluble P-selectin glycoprotein ligand. J Am Soc Nephrol. 2002;13:1937–45.PubMedGoogle Scholar
  81. 81.
    Chen L, Xu D, Gao Y, et al. Effect of donor JNK signal transduction inhibition on transplant outcome in brain dead rat model. Inflammation. 2011;35(1):122–9.Google Scholar
  82. 82.
    Kotsch K, Francuski M, Pascher A, et al. Improved long-term graft survival after HO-1 induction in brain-dead donors. Am J Transplant. 2006;6(3): 477–86.PubMedGoogle Scholar
  83. 83.
    Zhou HC, Ding WG, Cui XG, Pan P, Zhang B, Li WZ. Carbon monoxide inhalation ameliorates conditions of lung grafts from rat brain death donors. Chin Med J (Engl). 2008;121(15):1411–9.Google Scholar
  84. 84.
    Schaub M, Ploetz CJ, Gerbaulet D. Effect of dopamine on inflammatory status in kidneys of brain-dead rats. Transplantation. 2004;77:1333–40.PubMedGoogle Scholar
  85. 85.
    Hoeger S, Gottmann U, Liu Z, et al. Dopamine treatment in brain-dead rats mediates anti-inflammatory effects: the role of hemodynamic stabilization and D-receptor stimulation. Transpl Int. 2007;20(9): 790–9.PubMedGoogle Scholar
  86. 86.
    Hoeger S, Reisenbuechler A, Gottmann U, et al. Donor dopamine treatment in brain dead rats is associated with an improvement in renal function early after transplantation and a reduction in renal inflammation. Transpl Int. 2008;21(11):1072–80.PubMedGoogle Scholar
  87. 87.
    Nijboer WN, Ottens PJ, van Dijk A, van Goor H, Ploeg RJ, Leuvenink HG. Donor pretreatment with carbamylated erythropoietin in a brain death model reduces inflammation more effectively than erythropoietin while preserving renal function. Crit Care Med. 2010;38(4):1155–61.PubMedGoogle Scholar
  88. 88.
    Hoeger S, Bergstraesser C, Selhorst J, et al. Modulation of brain dead induced inflammation by vagus nerve stimulation. Am J Transplant. 2010;10(3):477–89.PubMedGoogle Scholar
  89. 89.
    Kotsch K, Ulrich F, Reutzel-Selke A, et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg. 2008;248(6):1042–50.PubMedGoogle Scholar
  90. 90.
    Venkateswaran RV, Dronavalli V, Lambert PA, et al. The proinflammatory environment in potential heart and lung donors: prevalence and impact of donor management and hormonal therapy. Transplantation. 2009;88(4):582–8.PubMedGoogle Scholar
  91. 91.
    Schnuelle P, Gottmann U, Hoeger S, et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA. 2009;302(10):1067–75.PubMedGoogle Scholar
  92. 92.
    Gottmann U, Brinkkoetter PT, Bechtler M. Effect of pre-treatment with catecholamines on cold preservation and ischemia/reperfusion-injury in rats. Kidney Int. 2006;70:321–8.PubMedGoogle Scholar
  93. 93.
    Gottmann U, Notheisen A, Brinkkoetter PT. Influence of donor pretreatment with dopamine on allogeneic kidney transplantation after prolonged cold storage in rats. Transplantation. 2005;79:1344–50.PubMedGoogle Scholar
  94. 94.
    Schnuelle P, Lorenz D, Mueller A. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation. Kidney Int. 1999;56:738–46.PubMedGoogle Scholar
  95. 95.
    Schnuelle P, Berger S, de Boer J. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation. 2001;72:455–63.PubMedGoogle Scholar
  96. 96.
    Schnuelle P, Yard BA, Braun C. Impact of donor dopamine on immediate graft function after kidney transplantation. Am J Transplant. 2004;4:419–26.PubMedGoogle Scholar
  97. 97.
    Kapper S, Beck G, Riedel S. Modulation of chemokine production and expression of adhesion molecules in renal tubular epithelial and endothelial cells by catecholamines. Transplantation. 2002;74:253–60.PubMedGoogle Scholar
  98. 98.
    Zeng Z, Huang HF, Chen MQ, Song F, Zhang YJ. Heme oxygenase-1 protects donor livers from ischemia/reperfusion injury: the role of kupffer cells. World J Gastroenterol. 2010;16(10):1285–92.PubMedGoogle Scholar
  99. 99.
    Tsuchihashi S, Tamaki T, Tanaka M, et al. Pyrrolidine dithiocarbamate provides protection against hypothermic preservation and transplantation injury in the rat liver: the role of heme oxygenase-1. Surgery. 2003;133(5):556–67.PubMedGoogle Scholar
  100. 100.
    Tullius SG, Nieminen-Kelha M, Buelow R. Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation. 2002;74:591–8.PubMedGoogle Scholar
  101. 101.
    Blydt-Hansen TD, Katori M, Lassman C. Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidney transplants from ischemia/reperfusion injury. J Am Soc Nephrol. 2003;14:745–54.PubMedGoogle Scholar
  102. 102.
    Kato H, Amersi F, Buelow R, et al. Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am J Transplant. 2001;1(2):121–8.PubMedGoogle Scholar
  103. 103.
    Pratschke J, Wilhelm MJ, Laskowski I. Influence of donor brain death on chronic rejection of renal transplants in rats. J Am Soc Nephrol. 2001;12: 2474–81.PubMedGoogle Scholar
  104. 104.
    Leist M, Ghezzi P, Grasso G. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science. 2004;305:239–42.PubMedGoogle Scholar
  105. 105.
    Coleman TR, Westenfelder C, Togel FE, et al. Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities. Proc Natl Acad Sci USA. 2006;103(15):5965–70.PubMedGoogle Scholar
  106. 106.
    Elkins LJ. Inhalational anesthesia for organ procurement: potential indications for administering inhalational anesthesia in the brain-dead organ donor. AANA J. 2010;78(4):293–9.PubMedGoogle Scholar
  107. 107.
    Yu CH, Beattie WS. The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis. Can J Anaesth. 2006;53(9):906–18.PubMedGoogle Scholar
  108. 108.
    Wever KE, Warle MC, Wagener FA, et al. Remote ischaemic preconditioning by brief hind limb ischaemia protects against renal ischaemia-reperfusion injury: the role of adenosine. Nephrol Dial Transplant. 2011;26(10):3108–17.PubMedGoogle Scholar
  109. 109.
    Waldow T, Alexiou K, Witt W, et al. Protection against acute porcine lung ischemia/reperfusion injury by systemic preconditioning via hind limb ischemia. Transpl Int. 2005;18(2):198–205.PubMedGoogle Scholar
  110. 110.
    Wang F, Birch SE, He R, et al. Remote ischemic ­preconditioning by hindlimb occlusion prevents liver ischemic/reperfusion injury: the role of high mobility group-box 1. Ann Surg. 2010;251(2): 292–9.PubMedGoogle Scholar
  111. 111.
    Konstantinov IE, Li J, Cheung MM, et al. Remote ischemic preconditioning of the recipient reduces myocardial ischemia-reperfusion injury of the ­denervated donor heart via a katp channel-dependent mechanism. Transplantation. 2005;79(12):1691–5.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Henri G. D. Leuvenink
    • 1
  • Marc A. Seelen
    • 1
  • Rutger J. Ploeg
    • 2
  1. 1.Departments of SurgeryUniversity Medical Center GroningenGroningenThe Netherlands
  2. 2.Nuffield Department of Surgical SciencesOxford Transplant Centre, Churchill Hospital, HeadingtonOxfordUK

Personalised recommendations